Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elongin B pseudogene 2 (ELOBP2, also known as TCEB2P2) is a human pseudogene related to the Elongin B gene (TCEB2). Pseudogenes are DNA sequences similar to functional genes but are typically non-functional due to mutations or deletions, and they are usually not transcribed into functional proteins. ELOBP2 does not code for a protein product and is not involved in canonical biological pathways, disease processes, or targeted pharmacology[4][5][6]. Key context: - ELOBP2 is a pseudogene and not a protein-coding gene or a functional receptor, enzyme, or other druggable target[5][6]. - It shares sequence similarity with the functional Elongin B gene, which is involved in transcription elongation and ubiquitination pathways; however, ELOBP2 does not have a known biological function[4][5][6]. - Because it is a pseudogene, there are no known drugs, disease associations, mechanisms of drug action, biomarker roles, or safety concerns[5][6]. - Listings in standard gene databases and gene compendia confirm this pseudogene status, distinguishing it from the functional Elongin B (ELOB), which is a regulatory protein in key complexes[5][6][4]. Thus, **ELOBP2 is not a functional therapeutic target**, and its primary relevance is in genomics rather than molecular or clinical pharmacology[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Elongin B pseudogene 2 (ELOBP2).